Privacyvoorkeur

MEDtalks houdt u graag op de hoogte van de laatste ontwikkelingen op uw interessegebied. Kies hieronder of u op de hoogte gehouden wilt blijven van de nieuwste programma's en nascholingen binnen uw interessegebieden. Klik hier voor meer informatie.


NCHIV 2022 Virtual

Startdatum: 22.11.2022 Einddatum: 22.11.2022

The live broadcast of NHCIV 2022 can be viewed on this page on Tuesday 22 november 2022. 

The 15th Netherlands Conference on HIV Pathogenesis, Epidemiology, Prevention and Treatment (NCHIV) is set to once again take place on-site at the Royal Tropical Institute (KIT) in Amsterdam on Tuesday 22 November 2022. It will in principle be an on-site conference, with an option to take part online.

NCHIV serves as platform for stakeholders in the Netherlands to share and discuss the latest insights and developments in research concerning the pathogenesis, epidemiology, prevention and treatment of HIV. The annual program hosted in English, includes invited lectures, presentations of original research by a national and international faculty, as well as sessions which link research to societal impact and policy development.

 

Program

 

The live broadcast of NHCIV 2022 can be viewed on this page on Tuesday 22 november 2022. 

The 15th Netherlands Conference on HIV Pathogenesis, Epidemiology, Prevention and Treatment (NCHIV) is set to once again take place on-site at the Royal Tropical Institute (KIT) in Amsterdam on Tuesday 22 November 2022. It will in principle be an on-site conference, with an option to take part online.

NCHIV serves as platform for stakeholders in the Netherlands to share and discuss the latest insights and developments in research concerning the pathogenesis, epidemiology, prevention and treatment of HIV. The annual program hosted in English, includes invited lectures, presentations of original research by a national and international faculty, as well as sessions which link research to societal impact and policy development.

 

Program

09:00 - 09:10 Opening and introductions Board stichting NCHIV
SESSION 1 Innovations in Treatment, Vaccines and Cure
Chairs: Monique Nijhuis (UMC Utrecht) and Bram Goorhuis (Amsterdam UMC)
09:10 - 09:35 Plenary: Antibody-based treatments for HIV Marina Caskey (The Rockefeller University, New York)
09:35 - 09:50 Moderated Q&A
09:50 - 10:00 O.01: Immunogenicity of an additional mRNA-1273 SARS-CoV-2 vaccination in people living with HIV with hyporesponse after primary vaccination Marlou Jongkees (Erasmus MC)
10:00 - 10:10 O.02: HIV-infected people in West-Kenya at higher risk of SARS-CoV-2 infection, symptomatic COVID-19, and COVID-19-related hospitalizations: Implications for COVID-19 vaccine prioritization in people living with HIV in Kenya Gloria Gomez-Perez (PharmAccess Foundation)
10:10 - 10:20 O.03: HIV-1 3’-polypurine tract mutations confer dolutegravir resistance by switching to an integration-independent replication mechanism via 1-LTR circles José Dekker (Amsterdam UMC)
10:20 - 10:30 O.04: The BAF complex inhibitor pyrimethamine reverses HIV-1 latency in people with HIV-1 on antiretroviral therapy Henrieke Prins (Erasmus MC)
10:30 - 10:55 Refreshment break
SESSION 2 Barriers to Testing, Removing the HIV Reservoir, and Reducing Transmission
Chairs: Maarten Schim van der Loeff (GGD Amsterdam) and Godelieve de Bree (Amsterdam UMC)
10:55 - 11:05 O.05: Evaluating the implementation of home-based sexual health care among men who have sex with men using the RE-AIM framework Hanneke Goense (Maastricht University, GGD Zuid Limburg)
11:05 - 11:15 O.06: HIV teams as a tool to improve HIV indicator condition-guided testing: the necessity of being aware Carlijn Jordans (Erasmus MC)
11:15 - 11:25 O.07: CRISPR-Cas attack on the HIV-1 provirus can cause unintended deletion of surrounding cellular DNA Ye Liu (Amsterdam UMC)
11:25 - 11:35 O.08: Detection of Intact HIV proviral DNA in the CNS of a virally suppressed HIV-infected individual Marieke Nühn (UMC Utrecht)
11:35 - 11:45 O.09: Transmission of (drug resistant) HIV between the Dutch Caribbean islands and the Netherlands Marije Hofstra (UMC Utrecht)
11:45 - 12:30 SHM Monitoring Report presentation Ard van Sighem (SHM)
Ferdinand Wit (SHM)
  Panel discussion: HIV in the Netherlands: have we reached the last mile? Elske Hoornenborg (GGD Amsterdam)
Mark Vermeulen (Aidsfonds)
Wouter Bierman (UMCG), Kai Jonas (Maastricht University)
Birgit van Benthem (RIVM)Modeator: Marc van der Valk (SHM, Amsterdam UMC)
12:30-14:00 Lunch & poster viewing
SESSION 3 Weighing in on cis- and transgender women, talking sex and eliminating HIV and HCV
Chairs: Tania Mudrikova (UMC Utrecht) and Olivier Richel (Radboudumc)
14:00-14:25 Plenary: Immune and hormonal mechanisms of cardiometabolic risk in women living with HIV Markella Zanni (Massachusetts General Hospital, Harvard University)
14:25-14:40 Moderated Q&A
14:40-14:50 O.10: Reversibility of TAF- and/or INSTI-associated weight gain Myrthe Verburgh (Amsterdam UMC)
14:50-15:00 O.11: Development of a sexual health-counselling program for HIV care providers during routine consultations; an Intervention Mapping approach Suzanne de Munnik (Catharina Ziekenhuis)
15:00-15:10 O.12: Assessing the HIV care continuum among transgender women between 2010 and 2020 in the Netherlands: does HIV care engagement differ from that of men who have sex with men? Elske Hoornenborg (GGD Amsterdam)
15:10-15:20 O.13: Elimination of the HIV-1 viral reservoir using DDX3 inhibitors Jade Jansen (Amsterdam UMC)
15:20-15:30 O.14: Progress towards WHO HCV elimination incidence targets among people with HIV: findings from the International Collaboration on Hepatitis C Elimination in HIV Cohorts Daniela van Santen (Burnet Institute Melbourne & GGD Amsterdam)
15:30-16:00 Refreshment break  
SESSION 4 Protecting the Mind and the Body in HIV
Chairs: Reina Foppen (Hiv Vereniging) and Peter Reiss    
16:00-16:25 Plenary: Scalable mental health interventions for HIV: lessons from research in the Global North and South Prof. Pamela Collins (UW Consortium for Global Mental Health, I-TECH, Seattle)
16:25-16:40 Moderated Q&A
16:40-16:50 Presentation of Joep Lange & Jacqueline van Tongeren Junior Investigator’s Award Board stichting NCHIV
16:50-17:30 Panel: Vaccination for people living with HIV: novel issues and implementation challenges Moderator: Bram Goorhuis (Amsterdam UMC)
Laura Laan (Amsterdam UMC)
Anna Roukens (LUMC)
Stella Zonneveld (Regional Association of General Practioners, ROHA)
Reina Foppen (Hiv Vereniging)
  Closing Board stichting NCHIV

Accreditation 
The continuing education points awarded for NCHIV 2022 will be announced soon on nchiv.org. Accreditation is being requested at:

  • Nederlandse Internisten Vereniging (NIV)
  • Nederlandse Vereniging voor Kindergeneeskunde (NVK)
  • Nederlandse Vereniging voor Medische Microbiologie (NVMM)
  • Openbaar apothekers (OA)
  • Ziekenhuisapothekers (ZA)
  • Accreditatiebureau Verpleegkundig Specialisten Register
  • Accreditatiebureau Kwaliteitsregister V&V en Register Zorgprofessionals

 

Contact details
NCHIV Organisation
Stichting hiv monitoring
Meibergdreef 9
1105 AZ Amsterdam 
The Netherlands 
Email: organisation@nchiv.org

    
   
 
     
   
     
     
     
     
   
   
 
     
     
     
     
     
     
     
   
   
 
     
   
     
     
     
     
     
     
   
     
     
   
     
     
     

Accreditation 
The continuing education points awarded for NCHIV 2022 will be announced soon on nchiv.org. Accreditation is being requested at:

  • Nederlandse Internisten Vereniging (NIV)
  • Nederlandse Vereniging voor Kindergeneeskunde (NVK)
  • Nederlandse Vereniging voor Medische Microbiologie (NVMM)
  • Openbaar apothekers (OA)
  • Ziekenhuisapothekers (ZA)
  • Accreditatiebureau Verpleegkundig Specialisten Register
  • Accreditatiebureau Kwaliteitsregister V&V en Register Zorgprofessionals

 

Contact details
NCHIV Organisation
Stichting hiv monitoring
Meibergdreef 9
1105 AZ Amsterdam 
The Netherlands 
Email: organisation@nchiv.org

Laatst bewerkt: 04-01-2023

  • Partners

    This program is powered by